NCT03023891View on ClinicalTrials.gov

Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

January 10, 2019

Study Completion Date

December 31, 2019

Conditions
Glucocorticoids ToxicityGlucose Intolerance
Interventions
DRUG

Prednisone

Prednisone 60 mg tablet once

Trial Locations (1)

37203

Vanderbilt University Medical Center -CRC, Nashville

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

Vanderbilt University Medical Center

OTHER

NCT03023891 - Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids | Biotech Hunter | Biotech Hunter